Q1 2025 908 Devices Inc Earnings Call Transcript
Key Points
- Revenue from continuing operations increased by 59% year-over-year, reaching $11.8 million.
- Recurring revenue grew by 54% from the previous year, representing 37% of total revenues.
- The company completed the divestiture of its biopharma desktop portfolio, strengthening its cash position.
- 908 Devices Inc (MASS) received significant orders, including a $2 million order from the Texas Department of Public Safety.
- The company is targeting positive adjusted EBITDA by Q4 2025 and full-year cash flow positivity in 2026.
- Gross margin decreased to 47% from 52% in the prior-year period, primarily due to intangible amortization from the RedWave acquisition.
- Net loss from continuing operations increased to $9.8 million compared to $5.9 million in the prior-year period.
- Total operating expenses rose to $16.6 million from $11.5 million in the prior-year period.
- The company is not assuming any meaningful revenue contribution from the US Department of Defense AVCAD program in 2025.
- There is potential risk of delays in the decision to move forward with full-rate production for the AVCAD program.
Hello, and welcome, everyone, to the 908 Devices first quarter 2025 financial results conference call. My name is Becky, and I'll be your operator today. (Operator Instructions) I will now hand over to your host, Kelly Gura, Investor Relations, to begin. Please go ahead.
Thank you. This morning, 908 Devices released financial results for the first quarter ended March 31, 2025. If you've not received this news release or if you'd like to be added to the company's distribution list, please send an e-mail to [email protected].
Joining me today from 908 is Kevin Knopp, Chief Executive Officer and Co-Founder; and Joe Griffith, Chief Financial Officer. Before we begin, our commentary today will include the presentation of some non-GAAP financial measures. These measures should be considered as a supplement to and not a substitute for GAAP financial measures.
Reconciliations of the most directly comparable GAAP financial measures can be found in today's earnings press release, which is available in
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
